| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084251213 |
| P356 | DOI | 10.1186/S12936-017-1762-7 |
| P932 | PMC publication ID | 5341168 |
| P698 | PubMed publication ID | 28270152 |
| P50 | author | Pedro M Folegatti | Q56380092 |
| Chris J Drakeley | Q56774786 | ||
| Wuelton Marcelo Monteiro | Q78298494 | ||
| André Machado Siqueira | Q28051167 | ||
| P2093 | author name string | Érika M Braga | |
| Marcus Vinícius G Lacerda | |||
| P2860 | cites work | [Health and indigenous peoples in Brazil: reflections based on the First National Survey of Indigenous People's Health and Nutrition] | Q88014043 |
| Challenges for malaria elimination in Brazil | Q26315456 | ||
| A historical perspective on malaria control in Brazil | Q26777737 | ||
| Information systems to support surveillance for malaria elimination | Q27008048 | ||
| Genomic analysis of local variation and recent evolution in Plasmodium vivax | Q27149930 | ||
| The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions | Q27860564 | ||
| Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
| Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein | Q28471832 | ||
| Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology | Q28740283 | ||
| Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea | Q28744515 | ||
| The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis | Q33526349 | ||
| Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian Amazon | Q33617528 | ||
| A research agenda for malaria eradication: monitoring, evaluation, and surveillance | Q33818025 | ||
| Isolation and characterization of the MSP1 genes from Plasmodium malariae and Plasmodium ovale | Q33880777 | ||
| Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure | Q33935818 | ||
| Using serological measures to monitor changes in malaria transmission in Vanuatu | Q33998176 | ||
| Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon. | Q34078790 | ||
| Epidemiology of disappearing Plasmodium vivax malaria: a case study in rural Amazonia | Q34104487 | ||
| Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis | Q34234390 | ||
| Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area. | Q34287358 | ||
| Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes | Q34359141 | ||
| Serologically defined variations in malaria endemicity in Pará state, Brazil | Q34565695 | ||
| B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax Merozoite Surface Protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon | Q34726966 | ||
| Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals | Q35606249 | ||
| In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9 | Q35898819 | ||
| Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities | Q35961275 | ||
| Use of different transmission metrics to describe malaria epidemiology in the highlands of western Kenya | Q36219438 | ||
| Antigenic polymorphism and naturally acquired antibodies to Plasmodium vivax merozoite surface protein 1 in rural Amazonians | Q36313424 | ||
| A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection--a review. | Q36544606 | ||
| Seroepidemiology of Plasmodium species infections in Zimbabwean population | Q36890504 | ||
| Serology: a robust indicator of malaria transmission intensity? | Q36995780 | ||
| Targeting the Plasmodium vivax Duffy-binding protein. | Q37006600 | ||
| High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms | Q37352099 | ||
| Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives | Q37557832 | ||
| Insights into the naturally acquired immune response to Plasmodium vivax malaria | Q38728598 | ||
| Cross-sectional study defines difference in malaria morbidity in two Yanomami communities on Amazonian boundary between Brazil and Venezuela. | Q39213798 | ||
| Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. | Q39417737 | ||
| Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil | Q39501018 | ||
| The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon | Q40919228 | ||
| A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. | Q42581710 | ||
| A seroprevalence and descriptive epidemiological study of malaria among Indian tribes of the Amazon basin of Brazil. | Q43213393 | ||
| Application of the Indirect Fluorescent Antibody Method in a Study of Malaria Endemicity in Mato Grosso, Brazil * | Q44140677 | ||
| Low Frequency of Anti-Plasmodium Falciparum Circumsporozoite Repeat Antibodies and Rate of High Malaria Transmission in Endemic Areas of Rondonia State in Northwestern Brazil | Q44142889 | ||
| Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region | Q44164222 | ||
| Malaria control in Brazil: 1965 to 2001 | Q44177964 | ||
| Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians. | Q44182636 | ||
| Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil. | Q44937152 | ||
| Sero-epidemiological studies on population groups previously exposed to malaria | Q46665247 | ||
| Sero-epidemiological surveillance of disappearing malaria in Greece | Q47839504 | ||
| Prevalence and level of antibodies to the circumsporozoite proteins of human malaria parasites, including a variant of Plasmodium vivax, in the population of two epidemiologically distinct areas in the state of Acre, Brazil | Q47853005 | ||
| Gamma-globulin and acquired immunity to human malaria | Q47957467 | ||
| Prevalence of antibodies against agents causing hepatitis, malaria, syphilis and toxoplasmosis in 5 different human populations of the Brazilian Amazonia | Q47986913 | ||
| Antibody response against Plasmodium falciparum exoantigens and somatic antigens: a longitudinal survey in a rural community in Rondônia, western Brazilian Amazon | Q48009756 | ||
| Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population. | Q48013929 | ||
| Humoral immune response to the 72 kDa heat shock protein from Plasmodium falciparum in populations at hypoendemic areas of malaria in western Brazilian Amazon | Q48036532 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| biomarker | Q864574 | ||
| systematic review | Q1504425 | ||
| globulins | Q321710 | ||
| blood proteins | Q425056 | ||
| protozoan antibodies | Q76122108 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 107 | |
| P577 | publication date | 2017-03-07 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | A systematic review on malaria sero-epidemiology studies in the Brazilian Amazon: insights into immunological markers for exposure and protection | |
| P478 | volume | 16 |
| Q59129806 | Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region |
| Q61445471 | Comparative analysis of IgG and IgG subclasses against Plasmodium falciparum MSP-1 in children from five contrasting bioecological zones of Cameroon |
| Q58752517 | IgG subclass responses to excreted-secreted antigens of Plasmodium falciparum in a low-transmission malaria area of the Peruvian Amazon |
| Q90243753 | Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers |
| Q90595442 | Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens |
| Q110697512 | Serology for Plasmodium vivax surveillance: A novel approach to accelerate towards elimination |
| Q58567578 | Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1 subunit proteins in multiplexed serologic assays |
| Q92089489 | [Malaria: immuno-permissive management in the prevention of transfusional malaria] |
Search more.